The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?
Keyword(s):
2017 ◽
Vol 6
(1)
◽
pp. 1
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):